Form 4: Ironwood Pharmaceuticals CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Sravan Kumar Emany, CFO of Ironwood Pharmaceuticals, disposed of shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 16, 2024, Sravan Kumar Emany, the SVP and Chief Financial Officer of Ironwood Pharmaceuticals, disposed of 18,280 shares of Class A Common Stock.
- The shares were sold at a price of $6.64.
- This transaction was to satisfy tax withholding obligations related to the vesting of performance-based restricted stock units.
- Following the transaction, Emany directly owns 320,573 shares of Ironwood Pharmaceuticals.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a normal course of business.
Industry Context
Form 4 filings are a routine part of insider trading activity and are used to disclose transactions by company insiders. This transaction is related to tax obligations, which is a common reason for share disposals.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of transaction: Sravan Kumar Emany disposed of shares. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.